Optimal therapies would normalize vasculature enough to access the tissue with cytotoxic compounds, but not be so prolonged as to completely degrade vascular access and force hypoxia-induced-tumor evolution to VEGF independence [63]. This evidence concerns the gene VEGFA and neoplasm.